Nicotine therapeutic benefits: Difference between revisions
Jump to navigation
Jump to search
Richardpruen (talk | contribs) (Added 2 studies on Parkinson's disease) |
Richardpruen (talk | contribs) (Added K. Fagerstrom paper) |
||
| Line 1,367: | Line 1,367: | ||
='''Suggested additions to this page'''= | ='''Suggested additions to this page'''= | ||
=== 2014 [http://journals.cambridge.org/abstract_S1834261214000279 Nicotine: Pharmacology, Toxicity and Therapeutic use] === | |||
* Karl Fagerström. Journal of Smoking Cessation, 9, pp 53-59 doi:10.1017/jsc.2014.27 | |||
* May need a new heading: general therapeutic use | |||
===2023: [https://pubmed.ncbi.nlm.nih.gov/37208927/ Inflammatory cytokines in alcohol use disorder patients are lower in smokers and users of smokeless tobacco]=== | ===2023: [https://pubmed.ncbi.nlm.nih.gov/37208927/ Inflammatory cytokines in alcohol use disorder patients are lower in smokers and users of smokeless tobacco]=== | ||